Related Experiment Videos
[The tongue in facial hemihypertrophy]
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale
|January 1, 1986
Summary
Hemifacial hypertrophy is a complex condition with varied causes, not a distinct disease. Early diagnosis is crucial, considering congenital factors, neural crest cell alterations, or secondary bone lesions.
Area of Science:
- Medical Science
- Genetics
- Pathology
Background:
- Hemifacial hypertrophy (HFH) is not a distinct disease but a complex condition with diverse etiologies.
- Initial diagnostic steps for HFH involve excluding tumors.
- HFH can manifest as a congenital condition, affecting one side of the body.
Observation:
- Congenital HFH may involve both hard and soft tissues, including the tongue.
- Alterations in neural crest cells are implicated in the cephalic organogenesis of HFH.
- The initial lesion in HFH may originate at a very early developmental stage.
Findings:
- HFH can be tissue-oriented, associated with nervous system conditions like neurofibromatosis or vascular anomalies such as Klippel-Trenaunay-Weber syndrome.
- Tongue involvement is noted in some vascular and nervous system-related HFH cases.
- Bone lesions, including fibrous osteopathies or hypercondylar disorders, can cause secondary HFH, often without tongue lesions.
Implications:
- Understanding the varied etiology of HFH is essential for accurate diagnosis and management.
- Identifying the underlying cause (congenital, neural crest, vascular, nervous, or bone-related) guides treatment strategies for hemifacial hypertrophy.
- The absence of tongue lesions can be a key diagnostic factor differentiating secondary HFH from other forms.